MALVERN, Pa.--(BUSINESS WIRE)--LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009. Based on protein domains having an affinity for ubiquitin, the laboratory directed by Dr. Rodriguez has developed Tandem-repeated Ubiquitin Binding Entities (TUBEs) to purify ubiquitylated proteins. TUBEs display up to a 1000-fold increase in affinity for poly-ubiquitin moieties over a single ubiquitin binding domain and are effective “Ubiquitin Traps”.
